Market Highlights

Delirium is a neurological (nervous system) condition and is a serious disturbance in mental abilities that causes mental confusion and emotional disruption. Delirium can be caused due to various factors such as older age, exposure to certain medications, alcohol abuse, surgery or other medical procedures, factors such as exposure to toxic or infectious agents, physical trauma, diet, and behavioral and occupational factors.

The Global Delirium Market growth is expected to grow at a CAGR of 6% during the forecast period.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/5850

Key Players

Some of the key players in the delirium market are Dr. Franz Kohler Chemie GmbH, Fraser Health, Gaia BioPharma Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute, Inc., and Air Liquide Sante International, among others.

Segmentation

The global delirium market is segmented on the basis of type, treatment, diagnosis, and end-user.

On the basis of type, the market is segmented into hyperactive, hypoactive, and mixed.

On the basis of diagnosis, the market is segmented into laboratory tests, imaging tests, and physical examination. On the basis of laboratory tests, it is further sub-segmented into blood tests and urine tests. On the basis of imaging tests, it is further sub-segmented into brain-imaging tests.

On the basis of treatment, the market is segmented into antipsychotics and supportive care. On the basis of treatment, antipsychotics is further sub-segmented into risperidone, olanzapine, and quetiapine.

On the basis of end-user, the market is segmented into specialty centers, hospitals, and research centers.

Regional Analysis

The Americas dominates the global delirium market owing to the increasing aging population and increasing rate of neurological conditions. Additionally, the increasing government initiatives and awareness programs are likely to enhance the growth of delirium in the North American region. Similarly, increasing government healthcare costs, along with the increasing awareness among population regarding mental health is expected to drive the growth of the delirium market in North America. For instance, iDelirium, a federation of 3 delirium societies (American Delirium Society, European Delirium Society, and Australasian Delirium Association) has launched various awareness programs across the country to spread awareness regarding delirium and its effects.

Europe accounts for the second largest market due to increasing aging mass and increasing neurological disorders. Additionally, the improving government funding and increasing healthcare infrastructure along with the increasing demand for technologically advanced treatment are driving the growth of delirium market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above. This rising older population is likely to drive the growth of the delirium market.

Access Report Details @ https://www.marketresearchfuture.com/reports/delirium-market-5850

More Related Report

Asia Pacific Aesthetics Market

Narcolepsy Market

Blepharitis Market

Delirium Market

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America